Needle biopsies on autopsy prostates: Sensitivity of cancer detection based on true prevalence

Journal of the National Cancer Institute

Volumn 99, Issue 19, 2007, Pages 1484-1489

  Haas, Gabriel P ^a   Delongchamps, Nicolas Barry ^a   Jones, Richard F ^a   Chandan, Vishal ^a   Serio, Angel M ^b   Vickers, Andrew J ^b   Jumbelic, Mary ^a,c   Threatte, Gregory ^a   Korets, Rus ^b   Lilja, Hans ^b   De La Roza, Gustavo ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Onondaga County Medical Examiner   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANATOMICAL VARIATION; ARTICLE; AUTOPSY; CANCER DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; PREVALENCE; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY ANALYSIS; TUMOR VOLUME; ETHNOLOGY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY; UNITED STATES;

AGE FACTORS; AGED; AUTOPSY; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC NEOPLASMS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN; UNITED STATES;

EID: 35148846265     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm153     Document Type: Article

References (26)

1. Master VA, Chi T, Simko JP, Weinberg V, Carroll PR. The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol 2005;174:1789-93.
2. Galper SL, Chen MH, Catalona WJ, Roehl KA, Richie JP, D'Amico AV. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol 2006;175:907-12.
3. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (T1c) prostate cancer. JAMA 1994;271:368-74.
4. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993;71:933-8.
5. Gosselaar C, Roobol MJ, Schroder FH. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant? BJU Int 2005;95:231-7.
6. Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med 2003;349:335-42.
7. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-85.
8. Soos G, Tsakiris I, Szanto J, Turzo C, Haas GP, Dezso B. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. Eur Urol 2005;48:739-44.
9. Sanchez-Chapado M, Olmedilla G, Cabeza M, Donat E, Ruiz A. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate 2003;54:238-47.
10. Stamatiou K, Alevizos A, Perimeni D, Sofras F, Agapitos E. Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study. Prostate Cancer Prostatic Dis 2005;9:45-9.
11. Klein EA. What is "insignificant" prostate carcinoma? Cancer 2004;101:1923-5.
12. Hameed O, Sublett J, Humphrey PA. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immuno- histochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues. Am J Surg Pathol 2005;29:579-87.
13. Troncoso P, Babaian RJ, Ro JY, Grignon DJ, von Eschenbach AC, Ayala AG. Prostatic intraepithelial neoplasia and invasive prostatic adenocarci- noma in cystoprostatectomy specimens. Urol 1989;34:52-6.
14. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) concensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005;29:1228-42.
15. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, editors, et al. AJCC cancer staging manual. 6th ed. New York (NY): Springer; 2002.
16. Noguchi M, Stamey TA, McNeal JE, Yemoto CE. Assessment of mor- phometric measurements of prostate carcinoma volume. Cancer 2000;89:1056-64.
17. Schned AR, Wheeler KJ, Hodorowski CA, Heaney J A, Ernstoff MS, Amdur RJ, et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol 1996;20:1501-6.
18. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006;175:1605-12.
19. Boccon-Gibod LM, Delongchamps NB, Toublanc M, Boccon-Gibod LA, Ravery V. Prostate saturation biopsy in the reevaluation of microfocal prostate cancer. J Urol 2006;176:961-3.
20. Brossner C, Bayer G, Madersbacher S, Kuber W, Klingler C, Pycha A. Twelve prostate biopsies detect significant cancer volumes (<0.5 mL). BJU Int 2000;85:705-7.
21. McNeal JE, Bostwick DG, Kindrachuck RA, Redwine EA, Freiha FS, Stamey TA. Patterns of progression in prostate cancer. Lancet 1986; 1:60-3.
22. Lowe BA, Listrom MB. Incidental carcinoma of the prostate: an analysis of the predictors of progression. J Urol 1988;140:1340-4.
23. Shiraishi T, Watanabe M, Matsuura H, Kusano I, Yatani R, Stemmermann GN. The frequency of latent prostatic carcinoma in young males: the Japanese experience. In Vivo 1994;8:445-7.
24. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24.
25. Konety BR, Bird VY, Deorah S, Dahmoush L. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol 2005;174:1785-8.
26. Patel AR, Jones JS, Rabets J, DeOreo G, Zippe CD. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology 2004;63:87-9.